Tata Chemicals’ Board of Directors has approved the unaudited consolidated and audited standalone financial results for Q3 2026, ending December 31, 2025. The board meeting, held on February 2, 2026, concluded at 4:15 p.m. (IST). The results are available on the company’s website and will be published in one English and one vernacular newspaper.
Financial Results Approved
The Board of Directors at Tata Chemicals has approved the unaudited consolidated and audited standalone financial results for the third quarter (Q3) and nine months ended December 31, 2025. The decision was made at a meeting held on February 2, 2026.
Q3 2026 Financial Highlights
Here are some key figures from the consolidated financial results:
- Revenue from operations: ₹3,550 crore
- Other income: ₹38 crore
- Total income: ₹3,588 crore
- Loss for the period: ₹(69) crore
- Total comprehensive income for the period: ₹884 crore
Segment Performance
The company’s revenue is divided into two major segments. Here’s a quick breakdown:
- Basic chemistry products: ₹2,887 crore
- Specialty products: ₹667 crore
These results will be published in one English and one vernacular newspaper and are available on the company’s website.
Source: BSE
